Kevin Love

Kevin helps manage the philanthropy's drug pricing reform grant portfolio. His work is focused on identifying new investments to promote drug-pricing reform while encouraging innovative research.

Before joining Arnold Ventures, Kevin was a manager at Avalere Health, where he oversaw FDA and regulatory strategy, with a focus on changes to biosimilars and generics. At Avalere, he also led engagements exploring value-based payment and commercialization issues for leading life science companies. Before that, he interned with the Alliance for Regenerative Medicine, a Washington, D.C.-based advocacy group representing cell and gene therapy manufacturers.

Kevin holds a master’s in biotechnology with a focus in business and policy from Georgetown University and a bachelor’s in chemistry from the University of North Carolina.